Shares of Core Laboratories NV (NYSE:CLB) gapped up prior to trading on Monday . The stock had previously closed at $115.02, but opened at $115.24. Core Laboratories NV shares last traded at $118.73, with a volume of 267,969 shares traded.

CLB has been the topic of several recent research reports. JPMorgan Chase & Co. restated a “buy” rating on shares of Core Laboratories NV in a research note on Thursday, June 30th. KLR Group restated a “buy” rating and issued a $180.00 price target (up previously from $166.00) on shares of Core Laboratories NV in a research note on Monday, June 13th. Royal Bank Of Canada restated a “buy” rating on shares of Core Laboratories NV in a research note on Saturday, April 23rd. Zacks Investment Research upgraded Core Laboratories NV from a “hold” rating to a “buy” rating and set a $138.00 price target on the stock in a research note on Wednesday, July 20th. Finally, Stephens upped their price target on Core Laboratories NV from $89.00 to $98.00 and gave the stock an “equal weight” rating in a research note on Friday, April 22nd. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the stock. Core Laboratories NV currently has a consensus rating of “Hold” and a consensus price target of $120.71.

The firm has a market cap of $5.28 billion and a price-to-earnings ratio of 63.53. The company’s 50 day moving average price is $120.02 and its 200-day moving average price is $115.22.

Core Laboratories NV (NYSE:CLB) last issued its quarterly earnings results on Wednesday, July 20th. The company reported $0.35 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.35. During the same period in the previous year, the company posted $0.81 earnings per share. The business had revenue of $148.10 million for the quarter, compared to analyst estimates of $146.37 million. The business’s revenue for the quarter was down 27.4% on a year-over-year basis. Equities analysts predict that Core Laboratories NV will post $1.57 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 15th. Stockholders of record on Monday, July 18th will be given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date is Thursday, July 14th.

Several institutional investors have modified their holdings of CLB. Comerica Bank increased its position in shares of Core Laboratories NV by 1.0% in the fourth quarter. Comerica Bank now owns 23,101 shares of the company’s stock worth $2,246,000 after buying an additional 239 shares during the last quarter. State of Wisconsin Investment Board bought a new stake in shares of Core Laboratories NV during the fourth quarter worth $3,327,000. Aberdeen Asset Management PLC UK bought a new stake in shares of Core Laboratories NV during the fourth quarter worth $5,554,000. Finally, Poplar Forest Capital LLC raised its stake in shares of Core Laboratories NV by 2.7% in the fourth quarter. Poplar Forest Capital LLC now owns 9,650 shares of the company’s stock worth $1,049,000 after buying an additional 250 shares during the period.

Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.